# Vir Biotechnology, Inc.: Form 8-K, filed May 6, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-05-06
- Accepted by EDGAR: May 6, 2026, 16:11 ET
- Period: 2026-05-06
- Accession: 0001628280-26-031273
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026031273/vir-20260506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828026031273/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828026031273/vir-20260506.htm

Filed May 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-031273. Last ingested by Listed: Nov 10, 2026, 17:35 ET. No prices; not investment advice.